{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T08:40:15Z","timestamp":1777020015477,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007798","name":"University of Helsinki Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"HUS Helsinki University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010129","name":"Maud Kuistila Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022793","name":"Turku University Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004756","name":"Emil Aaltonen Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijcha.2025.101861","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T04:33:33Z","timestamp":1767674013000},"page":"101861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Major bleeding complications and antithrombotic treatment after isolated surgical bioprosthetic aortic valve replacement"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1393-7743","authenticated-orcid":false,"given":"Rikhard","family":"Bj\u00f6rn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joonas","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Malmberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesa","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuomo","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha E.K.","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Biancari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E.Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-3741","authenticated-orcid":false,"given":"Tuomas","family":"Kiviniemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2025.101861_b0005","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101861_b0010","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1056\/NEJMoa1613792","article-title":"Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement","volume":"377","author":"Goldstone","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2025.101861_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS)","author":"Praz","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2025.101861_b0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCOUTCOMES.115.002696","article-title":"Safety and use of anticoagulation after aortic valve replacement with bioprostheses","volume":"9","author":"Riaz","year":"2016","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcha.2025.101861_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.amjcard.2023.07.097","article-title":"Antithrombotic medication and major complications after mechanical aortic valve replacement","volume":"204","author":"Bj\u00f6rn","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101861_b0030","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jtcvs.2019.12.114","article-title":"Adverse events and survival with postpericardiotomy syndrome after surgical aortic valve replacement","volume":"160","author":"Lehto","year":"2020","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcha.2025.101861_b0035","first-page":"157","article-title":"Occurrence and classification of cerebrovascular events after isolated bioprosthetic surgical aortic valve replacement: a competing risk analysis of the CAREAVR study, structural","volume":"2","author":"Lehto","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.ijcha.2025.101861_b0040","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.jtcvs.2021.03.101","article-title":"Late incidence and recurrence of new-onset atrial fibrillation after isolated surgical aortic valve replacement","volume":"164","author":"Bj\u00f6rn","year":"2022","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcha.2025.101861_b0045","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2025.101861_b0050","doi-asserted-by":"crossref","unstructured":"H.P. Adams, B.H. Bendixen, L.J. Kappelle, et al., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment., Stroke 24 (1993) 35\u201341. https:\/\/doi.org\/10.1161\/01.str.24.1.35.","DOI":"10.1161\/01.STR.24.1.35"},{"key":"10.1016\/j.ijcha.2025.101861_b0055","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1001\/jama.2012.54506","article-title":"Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality thromboembolic complications, and bleeding","volume":"308","author":"M\u00e9rie","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ijcha.2025.101861_b0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.athoracsur.2019.10.027","article-title":"Mechanical versus biologic prostheses for surgical aortic valve replacement in patients aged 50 to 70","volume":"110","author":"Kyt\u00f6","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ijcha.2025.101861_b0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5090\/jcs.23.143","article-title":"Mechanical versus bioprosthetic aortic valve replacement in patients aged 50 to 70 years","volume":"57","author":"Song","year":"2024","journal-title":"J. Chest Surg."},{"key":"10.1016\/j.ijcha.2025.101861_b0070","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jacc.2013.10.058","article-title":"Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement","volume":"63","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2025.101861_b0075","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2025.101861_b0080","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.febslet.2005.03.001","article-title":"The anticoagulant protein C pathway","volume":"579","author":"Dahlb\u00e4ck","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijcha.2025.101861_b0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.thromres.2016.11.021","article-title":"Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial","volume":"150","author":"Rafiq","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcha.2025.101861_b0090","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/jocs.14601","article-title":"Outcomes of isolated surgical aortic valve replacement in the era of transcatheter aortic valve implantation","volume":"35","author":"Ram","year":"2020","journal-title":"J. Card. Surg."},{"key":"10.1016\/j.ijcha.2025.101861_b0095","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2025.101861_b0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajh.10451","article-title":"Risk of bleeding complications with antiplatelet agents: meta\u2010analysis of 338,191 patients enrolled in 50 randomized controlled trials","volume":"75","author":"Serebruany","year":"2004","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ijcha.2025.101861_b0105","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jama.2014.12679","article-title":"Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years","volume":"312","author":"Chiang","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijcha.2025.101861_b0110","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/heartjnl-2019-315453","article-title":"Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement","volume":"106","author":"Christersson","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ijcha.2025.101861_b0115","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.113.002003","article-title":"Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the society of thoracic surgeons adult cardiac surgery national database","volume":"127","author":"Brennan","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2025.101861_b0120","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/archinte.167.13.1414","article-title":"Bleeding complications with warfarin use","volume":"167","author":"Wysowski","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcha.2025.101861_b0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2362.2009.02122.x","article-title":"Bleeding events in pulmonary arterial hypertension","volume":"39","author":"Opitz","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ijcha.2025.101861_b0130","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMcibr1205363","article-title":"From clinical observation to mechanism \u2014 heyde\u2019s syndrome","volume":"367","author":"Loscalzo","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcha.2025.101861_b0135","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehq021","article-title":"Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis","volume":"31","author":"Ducrocq","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2025.101861_b0140","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcha.2025.101861_b0145","first-page":"1","article-title":"Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study","volume":"00","author":"Lehto","year":"2025","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"10.1016\/j.ijcha.2025.101861_b0150","doi-asserted-by":"crossref","unstructured":"C.M. Otto, R.A. Nishimura, R.O. Bonow, et al., 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines, 2021. https:\/\/doi.org\/10.1161\/CIR.0000000000000923.","DOI":"10.1161\/CIR.0000000000000923"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725002647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725002647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:50:48Z","timestamp":1777017048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725002647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"alternative-id":["S2352906725002647"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101861","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Major bleeding complications and antithrombotic treatment after isolated surgical bioprosthetic aortic valve replacement","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101861"}}